9. Kalliomaki M., Salminen S., Arvilommi H. et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial // Lancet. 2001. Vol. 357. P. 1076–1079.
10. Kalliomaki M., Salminen S., Poussa T. et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial // Lancet. 2003. Vol. 361. P. 1869–1877.
11. Kukkonen K., Savilahti E., Haahtela T. et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial // J. Allergy Clin. Immunol. 2007. Vol. 119(1). P. 192–198.
12. http://www.rosminzdrav.ru. Стандарты терапии – атопический дерматит.
13. Srikanjana K. et al. Development of tablets containing probiotics: effects of formulation and processing parameters on bacterial viability // Internat. J. Pharmacut. 2009. Vol. 370. P. 54–60.
14. Leibovici V., Evron R., Axelrod O. et al. Imbalance of immune responses in patients with chronic and widespread fungal skin infection // Clin. Exp. Dermatol. 1995. Vol. 20(5). P. 390–394.
15. Ogawa H., Summerbell R.C., Clemons K.V. et al. Dermatophytes and host defence in cutaneous mycoses // Med. Mycol. 1998. Vol. 36 (Suppl. 1). P. 166–173.
16. Tateishi Y., Sato H., Akiyama M. et al. Severe generalized deep dermatophytosis due to Trichophyton rubrum (trichophytic granuloma) in a patient with atopic dermatitis // Arch. Dermatol. 2004. Vol. 140(5). P. 624–625.
17. Nissen D., Petersen L.J., Esch R. et al. IgE-sensitization to cellular and culture filtrates of fungal extracts in patients with atopic dermatitis //Ann. Allergy Asthma Immunol. 1998. Vol. 81(3). P. 247–255.
18. Dillon S.R., Sprecher C., Hammond A. et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice // Nat. Immunol. 2004. Vol. 5. P. 752–760.
19. Sonkoly E., Muller A., Lauerma A.I. et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation // J. Allergy Clin. Immunol. 2006. Vol. 117. P. 411–417.
20. Guzik T.J., Bzowska M., Kasprowicz A. et al. Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters// Clin. Exp. Allergy. 2005. Vol. 35. P. 448–455.
21. Devos S.A., van der Valk P.G. The relevance of skin prick tests for Pityrosporum ovale in patients with head and neck dermatitis // Allergy. 2000. Vol. 55(11). P. 1056–1058.
22. Rajka G., Barlinn C. On the significance of the trichophytin reactivity in atopic dermatitis // Acta Derm. Venereol. 1979. Vol. 59. P. 45–47.
23. Cesur S. Topical antibiotics and clinical use // Mikrobiyol. Bul. 2002. Vol. 36. P. 353–361.
24. Hendley J.O., Ashe K.M. Eradication of resident bacteria of normal human skin by antimicrobial ointment // Antimicrob. Agents Chemother. 2003. Vol. 47(6). P. 1988–1990.
25. Grzybowska W., Banaszczyk-Rus M., Tyski S. Interaction of aminoglycosides and the other antibiotic on selected bacterial strains // Med. Dosw. Mikrobiol. 2004. Vol. 56(3). P. 275–285.
26. Блатун Л.А. Местное медикаментозное лечение ран. Проблемы и новые возможности их решения //Consilium medicum. Хирургия. 2007. Vol. 1(9). P. 52–57.
27. Короткий Н.Г., Шарова Н.М., Сидоренко О.А. Банеоцин в терапии осложненных форм атопического дерматита // Клин. дерм. и вен. 2006. № 1. С. 97–100.
28. Кунгуров Н.В., Кохан М.М. Лечение атопического дерматита // Клин. дерм. и вен. 2006. № 4. С. 70–76.
29. Атопический дерматит: клин. рекомендации. – М., 2010.
30. Сергеев А.Ю., Сергеев Ю.В., Сергеев В.Ю. Новые концепции патогенеза, диагностики и терапии онихомикозов // Иммунология, аллергология, инфектология. 2007. № 3. С. 15–19.
31. Muhlbacher J.M. Naftifine: a topical allylamine antifungal agent // Clin. Dermatol. 1991. Vol. 9. P. 479–485.
32. Petranyi G., Georgopoulos A., Mieth H. In vivo antimycotic activity of naftifine // Antimicrob. Agents Chemother. 1981. Vol. 19(3). P. 390–392.
33. Monk J.P., Brogden R.N. Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses // Drugs. 1991. Vol. 42(4). P. 659–672.
34. Котрехова Л.П. Десятилетний опыт применения Экзодерила (Нафтифина) в терапии микозов кожи // Проблемы медицинской микологии. 2006. № 8(1). С. 8–10.